<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04134624</url>
  </required_header>
  <id_info>
    <org_study_id>A19-118</org_study_id>
    <nct_id>NCT04134624</nct_id>
  </id_info>
  <brief_title>EMS Prehospital Blood Culture Collection and Antibiotic Administration: A Two-Phase Pilot Project to Reduce Mortality in Patients With Severe Sepsis and Septic Shock</brief_title>
  <official_title>EMS Prehospital Blood Culture Collection and Antibiotic Administration: A Two-Phase Pilot Project to Reduce Mortality in Patients With Severe Sepsis and Septic Shock</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HealthPartners Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>HealthPartners Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to improve the outcomes for patients suffering from severe sepsis and&#xD;
      septic shock (SS/SS) by decreasing the time from first medical contact to antibiotic&#xD;
      administration. This is a stepwise study that aims to demonstrate the ability of paramedics&#xD;
      to accurately obtain blood cultures prior to hospital arrival, administer a broad spectrum&#xD;
      antibiotic and initiate IV fluid resuscitation in patients meeting predefined criteria for&#xD;
      SS/SS.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is designed to improve the outcomes for patients suffering from severe sepsis and&#xD;
      septic shock (SS/SS) by decreasing the time from first medical contact to antibiotic&#xD;
      administration. This is a pilot project. This is a stepwise study that will build on&#xD;
      previously published literature to demonstrate the ability of paramedics to accurately obtain&#xD;
      blood cultures prior to hospital arrival, administer a broad spectrum antibiotic and initiate&#xD;
      IV fluid resuscitation in patients meeting predefined criteria for SS/SS. The primary aim is&#xD;
      to take processes that have been developed for use in this patient population during&#xD;
      Emergency Department care and to advance these same processes &quot;downrange&quot; to initiate them&#xD;
      prior to hospital arrival. Early antibiotic administration has been shown to decrease&#xD;
      mortality in a time dependent fashion when implemented in hospitalized patients. The&#xD;
      investigators hypothesize that initiating antibiotics prior to hospital arrival will improve&#xD;
      morbidity and mortality while also addressing quality metrics that are publicly reported for&#xD;
      this patient population.&#xD;
&#xD;
      This pilot study will be conducted in two consecutive phases, responding to the following&#xD;
      aims.&#xD;
&#xD;
      Aim 1: Evaluate the feasibility that paramedics can obtain blood cultures from general&#xD;
      patients prior to hospital arrival with a contamination rate that is statistically equivalent&#xD;
      to that for blood cultures obtained in Emergency Department.&#xD;
&#xD;
      Aim 2 (primary aim): Investigate whether prehospital paramedic initiated broad spectrum&#xD;
      antibiotics, administered after blood cultures are obtained, will result in improved&#xD;
      mortality rates for patients, when compared to historical controls.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Recruitment for this study was halted in February 2020 due to the COVID-19 pandemic. The study&#xD;
    team was unable to continue enrollment due to decreased volumes (and the fact that COVID-19&#xD;
    mimics some of the signs and symptoms of severe sepsis)&#xD;
  </why_stopped>
  <start_date type="Actual">September 11, 2019</start_date>
  <completion_date type="Actual">July 8, 2021</completion_date>
  <primary_completion_date type="Actual">February 27, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>This is a stepwise study with two phases. In phase 1, all eligible patients have a blood culture collected. In phase 2, eligible patients have a blood culture collected and antibiotics started in the prehospital setting.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>In hospital mortality</measure>
    <time_frame>Through duration of hospitalization, average 1 week</time_frame>
    <description>Mortality during hospital admission following enrollment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ICU length of stay</measure>
    <time_frame>Through duration of ICU stay, average 3 days</time_frame>
    <description>Length of stay in ICU during hospital admission following enrollment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>Through duration of hospitalization, average 1 week</time_frame>
    <description>Length of stay of hospitalization following enrollment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>30 day mortality</measure>
    <time_frame>30 days</time_frame>
    <description>Mortality 30 days following enrollment</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">215</enrollment>
  <condition>Sepsis</condition>
  <condition>Sepsis, Severe</condition>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>Prehospital intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>All subjects enrolled in this study will receive a sepsis intervention bundle in the prehospital setting, including blood cultures, IV fluids, and antibiotics. These patients will be compared to historical controls.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Historical controls without prehospital sepsis intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sepsis care bundle</intervention_name>
    <description>Initiation of sepsis care bundle in prehospital setting, including collection of blood cultures, administration of antibiotics, and initiation of IV fluids</description>
    <arm_group_label>Prehospital intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Phase 1 (blood culture contamination rate quantification phase)&#xD;
&#xD;
          1. Hemodynamically stable patients ≥18 years old being transported by Lakeview EMS to&#xD;
             Lakeview Hospital who will have an intravenous access established as part of their&#xD;
             routine prehospital care are eligible for this study.&#xD;
&#xD;
          2. English speaker&#xD;
&#xD;
        Phase 2 (blood cultures + antibiotics prehospital)&#xD;
&#xD;
        a. Patients with fever &gt;38oC + ≥2 qSOFA who are being transported to Lakeview Hospital that&#xD;
        originate as a 911 call&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Phase 1:&#xD;
&#xD;
          1. Patients age &lt;18 years&#xD;
&#xD;
          2. Hemodynamic instability&#xD;
&#xD;
          3. Prisoners&#xD;
&#xD;
        Phase 2:&#xD;
&#xD;
          1. Documented allergy to Penicillin or inability to determine patient's medication&#xD;
             allergies&#xD;
&#xD;
          2. Prisoners&#xD;
&#xD;
          3. Pregnant patients&#xD;
&#xD;
          4. Patients being transferred from one hospital to another&#xD;
&#xD;
          5. Non-English speakers&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aaron Burnett, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HealthPartners Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lakeview Hospital</name>
      <address>
        <city>Stillwater</city>
        <state>Minnesota</state>
        <zip>55082</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Kadri SS, Rhee C, Strich JR, Morales MK, Hohmann S, Menchaca J, Suffredini AF, Danner RL, Klompas M. Estimating Ten-Year Trends in Septic Shock Incidence and Mortality in United States Academic Medical Centers Using Clinical Data. Chest. 2017 Feb;151(2):278-285. doi: 10.1016/j.chest.2016.07.010. Epub 2016 Jul 22.</citation>
    <PMID>27452768</PMID>
  </reference>
  <reference>
    <citation>Howell MD, Davis AM. Management of Sepsis and Septic Shock. JAMA. 2017 Feb 28;317(8):847-848. doi: 10.1001/jama.2017.0131.</citation>
    <PMID>28114603</PMID>
  </reference>
  <reference>
    <citation>Kumar A, Haery C, Paladugu B, Kumar A, Symeoneides S, Taiberg L, Osman J, Trenholme G, Opal SM, Goldfarb R, Parrillo JE. The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock: association with serum lactate and inflammatory cytokine levels. J Infect Dis. 2006 Jan 15;193(2):251-8. Epub 2005 Dec 13.</citation>
    <PMID>16362889</PMID>
  </reference>
  <reference>
    <citation>Ferrer R, Martin-Loeches I, Phillips G, Osborn TM, Townsend S, Dellinger RP, Artigas A, Schorr C, Levy MM. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014 Aug;42(8):1749-55. doi: 10.1097/CCM.0000000000000330.</citation>
    <PMID>24717459</PMID>
  </reference>
  <reference>
    <citation>Liu VX, Fielding-Singh V, Greene JD, Baker JM, Iwashyna TJ, Bhattacharya J, Escobar GJ. The Timing of Early Antibiotics and Hospital Mortality in Sepsis. Am J Respir Crit Care Med. 2017 Oct 1;196(7):856-863. doi: 10.1164/rccm.201609-1848OC.</citation>
    <PMID>28345952</PMID>
  </reference>
  <reference>
    <citation>Gaieski DF, Mikkelsen ME, Band RA, Pines JM, Massone R, Furia FF, Shofer FS, Goyal M. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med. 2010 Apr;38(4):1045-53. doi: 10.1097/CCM.0b013e3181cc4824.</citation>
    <PMID>20048677</PMID>
  </reference>
  <reference>
    <citation>Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M; Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001 Nov 8;345(19):1368-77.</citation>
    <PMID>11794169</PMID>
  </reference>
  <reference>
    <citation>Mouncey PR, Osborn TM, Power GS, Harrison DA, Sadique MZ, Grieve RD, Jahan R, Harvey SE, Bell D, Bion JF, Coats TJ, Singer M, Young JD, Rowan KM; ProMISe Trial Investigators. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015 Apr 2;372(14):1301-11. doi: 10.1056/NEJMoa1500896. Epub 2015 Mar 17.</citation>
    <PMID>25776532</PMID>
  </reference>
  <reference>
    <citation>Peake SL, Delaney A, Bellomo R; ARISE Investigators. Goal-directed resuscitation in septic shock. N Engl J Med. 2015 Jan 8;372(2):190-1. doi: 10.1056/NEJMc1413936.</citation>
    <PMID>25564906</PMID>
  </reference>
  <reference>
    <citation>Lane D, Ichelson RI, Drennan IR, Scales DC. Prehospital management and identification of sepsis by emergency medical services: a systematic review. Emerg Med J. 2016 Jun;33(6):408-13. doi: 10.1136/emermed-2015-205261. Epub 2016 Feb 10. Review.</citation>
    <PMID>26864327</PMID>
  </reference>
  <reference>
    <citation>Walchok JG, Pirrallo RG, Furmanek D, Lutz M, Shope C, Giles B, Gue G, Dix A. Paramedic-Initiated CMS Sepsis Core Measure Bundle Prior to Hospital Arrival: A Stepwise Approach. Prehosp Emerg Care. 2017 May-Jun;21(3):291-300. doi: 10.1080/10903127.2016.1254694. Epub 2016 Dec 5.</citation>
    <PMID>27918869</PMID>
  </reference>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 16, 2019</study_first_submitted>
  <study_first_submitted_qc>October 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 22, 2019</study_first_posted>
  <last_update_submitted>September 16, 2021</last_update_submitted>
  <last_update_submitted_qc>September 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

